As obesity is associated with reduced adiponectin levels via multiple mechanisms, including decreased levels of SirT1, hyperinsulinemia, oxidative stress, and inflammation [87], decreased levels of circulating adiponectin in NAFLD are related to a decrease in hepatic insulin sensitivity and increase in the amount of hepatic fat content [88]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.